Pepsin and Laryngeal and Hypopharyngeal Carcinomas

다국어 초록 (Multilingual Abstract)

Laryngeal and hypopharyngeal carcinomas are common malignant tumors of the head and neck, and the incidence of both is increasing. Laryngopharyngeal reflux refers to the retrograde flow of gastric contents into the larynx, oropharynx, and/or nasopharynx. It remains controversial whether laryngopharyngeal reflux is a risk factor for laryngeal and hypopharyngeal cancers. The refluxing substances mainly include hydrochloric acid, pepsin, and occasionally bile acids and bile salts, as well as bacteria that colonize the gastrointestinal tract. Loss of epithelium in the mucous membrane of the larynx and hypopharynx is thought to be caused by pepsin. Here, we review the relationships between laryngopharyngeal reflux and both laryngeal and hypopharyngeal carcinomas, as well as the significance of pepsin, methods of clinical detection, and the mechanism of carcinogenesis.

참고문헌 (Reference)

1 Piper DW, "pH stability and activity curves of pepsin with special reference to their clinical importance" 6 (6): 506-508, 1965

2 Wilson JA, "What is the evidence that gastroesophageal reflux is involved in the etiology of laryngeal cancer?" 13 (13): 97-100, 2005

3 Lechien JR, "Validity and reliability of the reflux symptom score" 130 (130): E98-E107, 2020

4 Lechien JR, "Validity and reliability of the reflux sign assessment" 129 (129): 313-325, 2020

5 McGlashan JA, "The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux" 266 (266): 243-251, 2009

6 Strugala V, "The role of an alginate suspension on pepsin and bile acids: key aggressors in the gastric refluxate: does this have implications for the treatment of gastro-oesophageal reflux disease?" 61 (61): 1021-1028, 2009

7 Galli J, "The role of acid and alkaline reflux in laryngeal squamous cell carcinoma" 112 (112): 1861-1865, 2002

8 Koufman JA, "The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury" 101 (101): 1-78, 1991

9 Du X, "The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China" 17 (17): 107-, 2017

10 Tashian RE, "The carbonic anhydrases: widening perspectives on their evolution, expression and function" 10 (10): 186-192, 1989

11 Galera-Ruiz H, "The cadherin-catenin complex in laryngeal squamous cell carcinoma" 269 (269): 1183-1188, 2012

12 정은재, "The Role of Transnasal Esophagoscopy in ENT Office: A Prospective, Multicenter Study in Korea" 대한이비인후과학회 7 (7): 123-125, 2014

13 태경, "The Role of Laryngopharyngeal Reflux as a Risk Factor in Laryngeal Cancer: A Preliminary Report" 대한이비인후과학회 4 (4): 101-104, 2011

14 Kannan KK, "Structure, refinement, and function of carbonic anhydrase isozymes: refinement of human carbonic anhydrase I" 429 : 49-60, 1984

15 Knight J, "Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux" 115 (115): 1473-1478, 2005

16 Dy F, "Salivary pepsin lacks sensitivity as a diagnostic tool to evaluate extraesophageal reflux disease" 177 : 53-58, 2016

17 Hanson DG, "Role of esophageal pH recording in management of chronic laryngitis: an overview" 184 : 4-9, 2000

18 Maldhure S, "Role of PH monitoring in laryngopharyngeal reflux patients with voice disorders" 28 (28): 377-383, 2016

19 Faggons CE, "Review: head and neck squamous cell carcinoma in sub-Saharan Africa" 27 (27): 79-87, 2015

20 Sifrim D, "Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms" 29 (29): 1003-1017, 2007

21 Coca-Pelaz A, "Relationship between reflux and laryngeal cancer" 35 (35): 1814-1818, 2013

22 Hammer HF, "Reflux-associated laryngitis and laryngopharyngeal reflux: a gastroenterologist’s point of view" 27 (27): 14-17, 2009

23 Bardhan KD, "Reflux revisited: advancing the role of pepsin" 2012 : 646901-, 2012

24 Francis DO, "Reevaluation of gastroesophageal reflux disease as a risk factor for laryngeal cancer" 121 (121): 102-105, 2011

25 Johnston N, "Receptor-mediated uptake of pepsin by laryngeal epithelial cells" 116 (116): 934-938, 2007

26 Johnston N, "Rationale for targeting pepsin in the treatment of reflux disease" 119 (119): 547-558, 2010

27 Saritas Yuksel E, "Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease" 122 (122): 1312-1316, 2012

28 Reimer C, "Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor" 43 (43): 899-909, 2016

29 Nath K, "Proton-pump inhibitor overuse: a cautionary tale in misguided benefit" 49 (49): 1337-, 2019

30 Mikulski RL, "Proton transfer in catalysis and the role of proton shuttles in carbonic anhydrase" 1804 (1804): 422-426, 2010

31 Hu Q, "Proton pump inhibitors do not reduce the risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: a systematic review and meta-analysis" 121 (121): e0169691-, 2017

32 Hvid-Jensen F, "Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett’s oesophagus: a nationwide study of 9883 patients" 39 (39): 984-991, 2014

33 Freilich R, "Protein-protein interactions in the molecular chaperone network" 51 (51): 940-949, 2018

34 Wu K, "Protein folding while chaperone bound is dependent on weak interactions" 10 (10): 4833-, 2019

35 Delshad SD, "Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms" 158 (158): 1250-1261, 2020

36 Mosli M, "Prevalence and clinical predictors of LPR among patients diagnosed with GERD according to the reflux symptom index questionnaire" 24 (24): 236-241, 2018

37 Johnston N, "Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration" 1434 (1434): 282-289, 2018

38 Hurley BP, "Pepsin triggers neutrophil migration across acid damaged lung epithelium" 9 (9): 13778-, 2019

39 Johnston N, "Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells" 122 (122): 1317-1325, 2012

40 Niu K, "Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation" 15 (15): e0227408-, 2020

41 Tan JJ, "Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma" 19 : 64-, 2019

42 Hayat JO, "Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease" 64 (64): 373-380, 2015

43 Guo Z, "Pepsin in saliva as a diagnostic marker for gastroesophageal reflux disease: a meta-analysis" 24 : 9509-9516, 2018

44 Fortunato JE, "Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients" 29 (29): e12936-, 2017

45 Samuels TL, "Pepsin as a causal agent of inflammation during nonacidic reflux" 141 (141): 559-563, 2009

46 Johnston N, "Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease" 114 (114): 2129-2134, 2004

47 Sereg-Bahar M, "Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux: a prospective comparative study" 40 (40): 234-239, 2015

48 Poelmans J, "Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux?" 49 (49): 1868-1874, 2004

49 Lee YJ, "Optimization of saliva collection and immunochromatographic detection of salivary pepsin for point-of-care testing of laryngopharyngeal reflux" 20 (20): 325-, 2020

50 Na SY, "Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux" 126 (126): 2770-2773, 2016

51 Hayat JO, "Objective detection of esophagopharyngeal reflux in patients with hoarseness and endoscopic signs of laryngeal inflammation" 48 (48): 318-327, 2014

52 Nilsson M, "No association between gastroesophageal reflux and cancers of the larynx and pharynx" 14 (14): 1194-1197, 2005

53 Samuels TL, "Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux" 117 (117): 688-695, 2008

54 Zhang F, "MicroRNA‑143‑3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k‑Ras/Raf/MEK/ERK signaling pathway" 54 (54): 689-701, 2019

55 Forero-Quintero LS, "Membrane-anchored carbonic anhydrase IV interacts with monocarboxylate transporters via their chaperones CD147 and GP70" 294 (294): 593-607, 2019

56 Du E, "Long-term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status" 129 (129): 2506-2513, 2019

57 Bates JE, "Locally advanced hypopharyngeal and laryngeal cancer: influence of HPV status" 140 : 6-9, 2019

58 Samuels T, "Local synthesis of pepsin in Barrett’s esophagus and the role of pepsin in esophageal adenocarcinoma" 124 (124): 893-902, 2015

59 Belafsky PC, "Laryngopharyngeal reflux: the value of otolaryngology examination" 10 (10): 278-282, 2008

60 Koufman JA, "Laryngopharyngeal reflux is different from classic gastroesophageal reflux disease" 81 (81): 7-9, 2002

61 Lechien JR, "Laryngopharyngeal reflux and voice disorders: a multifactorial model of etiology and pathophysiology" 31 (31): 733-752, 2017

62 Shimazu R, "Laryngeal granuloma in experimental rats with gastroesophageal reflux disease and mechanically injured vocal cord mucosa" 123 (123): 247-251, 2014

63 El-Serag HB, "Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial" 96 (96): 979-983, 2001

64 Doustmohammadian N, "Is there any association between esophagogastric endoscopic findings and laryngeal cancer?" 32 (32): 490-493, 2011

65 Ozlugedik S, "Is laryngopharyngeal reflux an important risk factor in the development of laryngeal carcinoma?" 263 (263): 339-343, 2006

66 Monti DM, "Insights into the role of reactive sulfhydryl groups of Carbonic Anhydrase III and VII during oxidative damage" 32 (32): 5-12, 2017

67 Welch WJ, "Influence of molecular and chemical chaperones on protein folding" 1 (1): 109-115, 1996

68 Kim SY, "Increased risk of larynx cancer in patients with gastroesophageal reflux disease from a national sample cohort" 44 (44): 534-540, 2019

69 LeBlanc B, "Increased pharyngeal reflux in patients treated for laryngeal cancer: a pilot study" 153 (153): 791-794, 2015

70 Sasaki CT, "In vitro model for gastroduodenal reflux-induced nuclear factor-kappaB activation and its role in hypopharyngeal carcinogenesis" 38 (38): E1381-E1391, 2016

71 Gtari W, "Impact of macromolecular crowding on structure and properties of pepsin and trypsin" 72 : 98-105, 2017

72 Van Roon AH, "Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa" 12 (12): 1331-1340, 2008

73 Jiang A, "Immunohistochemical detection of pepsin in laryngeal mucosa for diagnosing laryngopharyngeal reflux" 121 (121): 1426-1430, 2011

74 Komatsu Y, "Hypopharyngeal pepsin and Sep70 as diagnostic markers of laryngopharyngeal reflux: preliminary study" 29 (29): 1080-1087, 2015

75 Geterud A, "Hypopharyngeal acid exposure: an independent risk factor for laryngeal cancer?" 113 (113): 2201-2205, 2003

76 Acuna G, "Human papillomavirus in laryngeal and hypopharyngeal lymphoepithelial carcinoma" 32 (32): 621-626, 2019

77 Sereg-Bahar M, "Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer" 49 (49): 59-64, 2015

78 Copper MP, "High incidence of laryngopharyngeal reflux in patients with head and neck cancer" 110 (110): 1007-1011, 2000

79 Basseri B, "Heterotopic gastric mucosa (inlet patch) in a patient with laryngopharyngeal reflux (LPR) and laryngeal carcinoma: a case report and review of literature" 22 (22): E1-E5, 2009

80 Marur S, "Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment" 91 (91): 386-396, 2016

81 Rooper LM, "HPV-positive squamous cell carcinoma of the larynx, oral cavity, and hypopharynx: clinicopathologic characterization with recognition of a novel warty variant" 44 (44): 691-702, 2020

82 Wilkie MD, "Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux" 275 (275): 2515-2521, 2018

83 Nason KS, "Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis" 146 (146): 851-858, 2011

84 El-Serag HB, "Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer" 96 (96): 2013-2018, 2001

85 Busch EL, "Gastroesophageal reflux disease and odds of head and neck squamous cell carcinoma in North Carolina" 126 (126): 1091-1096, 2016

86 Qadeer MA, "Gastroesophageal reflux and laryngeal cancer: causation or association? A critical review" 27 (27): 119-128, 2006

87 Zhang D, "Gastroesophageal reflux and carcinoma of larynx or pharynx: a meta-analysis" 134 (134): 982-989, 2014

88 Parsel SM, "Gastroesophageal and laryngopharyngeal reflux associated with laryngeal malignancy: a systematic review and meta-analysis" 17 (17): 1253-1264, 2019

89 Langevin SM, "Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma" 22 (22): 1061-1068, 2013

90 Noordzij JP, "Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study" 111 (111): 2147-2151, 2001

91 Lechien JR, "Evaluation and management of laryngopharyngeal reflux disease: state of the art review" 160 (160): 762-782, 2019

92 Ford CN, "Evaluation and management of laryngopharyngeal reflux" 294 (294): 1534-1540, 2005

93 Samuels TL, "Esophageal pepsin and proton pump synthesis in barrett’s esophagus and esophageal adenocarcinoma" 129 (129): 2687-2695, 2019

94 Alam MS, "Epidemiological profile of head and neck cancer patients in Western Uttar Pradesh and analysis of distributions of risk factors in relation to site of tumor" 13 (13): 430-435, 2017

95 Velanovich V, "Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned" 148 (148): 646-653, 2010

96 Johnston N, "Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease" 115 (115): 47-58, 2006

97 Eherer AJ, "Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study" 38 (38): 462-467, 2003

98 Ten Kate RW, "Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man" 35 (35): 173-176, 1988

99 Smit CF, "Effect of cigarette smoking on gastropharyngeal and gastroesophageal reflux" 110 (110): 190-193, 2001

100 Lao-Sirieix P, "Effect of acid suppression on molecular predictors for esophageal cancer" 15 (15): 288-293, 2006

101 Reichel O, "E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux" 265 (265): 937-942, 2008

102 Wood JM, "Does gene expression in laryngeal subsites differ between patients with laryngopharyngeal reflux and controls?" 43 (43): 158-163, 2018

103 Raja Nhari RM, "Detection of porcine pepsin in model cheese using polyclonal antibody-based ELISA" 37 (37): 561-567, 2020

104 Riley CA, "Detection of laryngeal carcinoma in the U.S. elderly population with gastroesophageal reflux disease" 41 (41): 1434-1440, 2019

105 Wight R, "Current theories for the development of nonsmoking and nondrinking laryngeal carcinoma" 11 (11): 73-77, 2003

106 Best AR, "Current indications for transnasal esophagoscopy: an american broncho-esophagological association survey" 127 (127): 926-930, 2018

107 Samuels TL, "Curcumin and anthocyanin inhibit pepsin-mediated cell damage and carcinogenic changes in airway epithelial cells" 122 (122): 632-641, 2013

108 Ju H, "Comparison of the structural characteristics of native collagen fibrils derived from bovine tendons using two different methods: modified acid-solubilized and pepsin-aided extraction" 13 (13): 358-, 2020

109 Formanek M, "Comparison of impedance and pepsin detection in the laryngeal mucosa to determine impedance values that indicate pathological laryngopharyngeal reflux" 8 (8): e123-, 2017

110 Tutuian R, "Characteristics of symptomatic reflux episodes on acid suppressive therapy" 103 (103): 1090-1096, 2008

111 Johnston N, "Cell biology of laryngeal epithelial defenses in health and disease: further studies" 112 (112): 481-491, 2003

112 Takeichi M, "Cadherins in cancer: implications for invasion and metastasis" 5 (5): 806-811, 1993

113 Alimperti S, "CDH2 and CDH11 act as regulators of stem cell fate decisions" 14 (14): 270-282, 2015

114 Doukas SG, "Biliary tumorigenic effect on hypopharyngeal cells is significantly enhanced by pH reduction" 8 (8): 4417-4427, 2019

115 Sasaki CT, "Biliary reflux as a causal factor in hypopharyngeal carcinoma: new clinical evidence and implications" 125 (125): 3554-3565, 2019

116 Anis MM, "Association of gastroesophageal reflux disease and laryngeal cancer" 4 (4): 278-281, 2018

117 Sharma N, "An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring" 6 (6): 521-524, 2008

118 Postma GN, "Ambulatory pH monitoring methodology" 184 : 10-14, 2000

119 Yadlapati R, "Abilities of oropharyngeal pH tests and salivary pepsin analysis to discriminate between asymptomatic volunteers and subjects with symptoms of laryngeal irritation" 14 (14): 535-542, 2016

120 Walentek P, "ATP4a is required for development and function of the Xenopus mucociliary epidermis: a potential model to study proton pump inhibitor-associated pneumonia" 408 (408): 292-304, 2015

121 Nurgalieva ZZ, "A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer" 27 (27): 22-27, 2005